Zobrazeno 1 - 1
of 1
pro vyhledávání: '"BAYER PHARMA SCHERING AG"'
The invention refers to the use of a fusion protein comprising an interleukin-2 part and an antibody part, specifically recognising the extra domain B of fibronectin, for treatment of a special form of cancer. Further, the invention refers to a combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::7784fa429fc0265781feff33a0e14547
https://register.epo.org/application?number=EP2007003343
https://register.epo.org/application?number=EP2007003343
